Analysis of survival and timing of non-lethal complications after mitral valve replacement with mechanical prostheses

   The aim of the study. To study the structure of lethal and non-lethal complications with an analysis of survival and the likelihood of non-lethal complications after mitral valve (MV) replacement with bicuspid mechanical prostheses over a five-year period.
   Materials and methods. The data of 260 patients who were treated in the period of 2012–2014 were analyzed a surgical intervention was performed – isolated MV prosthetics with mechanical bivalve prostheses. Among the patients, there were 84 (32.3 %) men and 176 (67.7 %) women. The median age was 51.0 [44.0–55.5] years. Statistical analysis was carried out using IBM SPSS Statistics 26.0 (USA).
   Results of the study and conclusions. According to the results of the five-year survival after MV prosthetics with mechanical prostheses, it was 86.6 %. At the same time, acute cardiovascular diseases (myocardial infarction, cardiac arrhythmias) were the leading cause of death. Among non-lethal thromboembolic complications, acute cerebrovascular accident prevailed, it developed in 65.3 %. Among nonlethal hypocoagulation complications, nosebleeds were most often recorded – in 40.5 % of patients. The probability of developing non-lethal thromboembolic complications by the fifth year is 20.0 % vs 18.5 % in the first six months after prosthetics with mechanical prostheses. And the probability of developing non-lethal hypocoagulation complications by the fifth year is 26.8 % vs 6.1 % in the first six months after prosthetics with mechanical prostheses.

1. Сазоненков М. А. Оперированный порок митрального клапана. Структура этиологии и видов оперативных вмешательств за период 2015–2020 гг. в кардиохирургическом отделении БОКБ Святителя Иоасафа / М. А. Сазоненков [и др.] // Актуальные проблемы медицины. – 2020/ – 43 (4): 590–602. DOI: 10.18413/2687–0940–2020–43–4–590–602. / Sazonenkov M. A., Ismatov H. Kh., Ernst E. E., Moskalev A. S., Kuzubova A. V., Askari I. V., Blizhenskaya N. N., Kovalenko I. B. Operated defect of the mitral valve. The structure of the etiology and types of surgical interventions for the period 2015–2020 in the cardiosurgical department of the St. Ioasaph Regional Clinical Hospital. Actual Problems of Medicine. 2020; 43 (4): 590–602. DOI: 10.18413/2687–0940–2020–43–4–590–602.

2. Tomšič A., Hiemstra Y. L., van Brakel T. J., Versteegh M. I. M., Marsan N. A., Klautz R. J. M., Palmen M. Outcomes of Valve Repair for Degenerative Disease in Patients with Mitral Annular Calcification. Ann Thorac Surg. 2019; 107 (4): 1195–1201. DOI: 10.1016/j.athoracsur.2018.08.017.

3. Hu X., Jiang W., Xie M., Guo R., Yim W. Y., Dong N., Wang Y. Bioprosthetic vs mechanical mitral valve replacement for infective endocarditis in patients aged 50 to 69 years. Clin Cardiol. 2020; 43 (10): 1093–1099. DOI: 10.1002/clc.23407.

4. Bal U., Aydinalp A., Yilmaz K., Ozcalik E., Hasirci S., Atar I., Gultekin B., Sezgin A., Muderrisoglu H. The effects of a low international normalized ratio on thromboembolic and bleeding complications in patients with mechanical mitral valve replacement. J Cardiothorac Surg. 201; 9 (79). DOI: 10.1186/1749–8090–9–79.

5. Aimo A., Emdin M., De Caterina R. Low-Thrombogenicity Mechanical Heart Valves: Which Antithrombotic Strategy? J Am Coll Cardiol. 2018; 9; 72 (15): 1878–1879. DOI: 10.1016/J.JACC.2018.07.065

6. Lim W. Y., Lloyd G., Bhattacharyya S. Mechanical and surgical bioprosthetic valve thrombosis. Heart. 2017; 103 (24): 1934–1941. DOI: 10.1136/heartjnl-2017–311856.

7. Новоселова А. А. Тромбоз механического клапана сердца: трудности диагностики на примере клинического случая с летальным исходом / А. А. Новоселова, С. С. Якушин // Рациональная фармакотерапия в кардиологии. – 2020. – 16 (3): 399–403. DOI: 10.20996/1819–6446–2020–06–13. / Novoselova A. A., Yakushin S. S. Thrombosis of a mechanical heart valve: diagnostic difficulties in a clinical case with a fatal outcome. Rational pharmacotherapy in cardiology. 2020; 16 (3): 399–403. DOI: 10.20996/1819–6446–2020–06–13.

8. Grzymala-Lubanski B., Svensson P. J., Renlund H., Jeppsson A., Själander A. Warfarin treatment quality and prognosis in patients with mechanical heart valve prosthesis. Heart. 2017; 103 (3): 198–203. DOI: 10.1136/heartjnl-2016–309585.

9. Рекомендации ESC/EACTS 2017 по лечению клапанной болезни сердца. Клинические рекомендации. Рабочая группа по ведению пациентов с клапанной болезнью сердца Европейского общества кардиологов (ЕОК, ESC) и Европейской ассоциации кардио-торакальной хирургии (EACTS) // Российский кардиологический журнал. – 2018. – 23 (7): 103–155. DOI: 10.15829/1560–4071–2018–7–103–155. / ESC/EACTS 2017 guidelines for the management of valvular heart disease. Clinical guidelines. European Society of Cardiology (ESC) and European Association for Cardiothoracic Surgery (EACTS) Working Group for the Management of Patients with Valvular Heart Disease. Russian Journal of Cardiology. 2018; 23 (7): 103–155. DOI: 10.15829/1560–4071–2018–7–103–155.

10. Corinne W. Tan, MD, Matthew Wall, M. D., Todd K. Rosengart, M. D., and Ravi K. Ghanta, M. D. How to bridge? Management of anticoagulation in patients with mechanical heart valves undergoing noncardiac surgical procedures. J Thorac Cardiovasc Surg. 2019; 158: 200–203. DOI: 10.1016/j.jtcvs.2018.06.089.

11. Chu M. W. A., Ruel M., Graeve A., Gerdisch M. W., Damiano R. J. Jr, Smith R. L., Keeling W. B., Wait M. A., Hagberg R. C., Quinn R. D., Sethi G. K., Floridia R., Barreiro C. J., Pruitt A. L., Accola K. D., Dagenais F., Markowitz A. H., Ye J., Sekela M. E., Tsuda R. Y., Duncan D. A., Swistel D. G., Harville L. E., DeRose J. J., Lehr E. J., Puskas J. D. PROACT Mitral Investigators. Low-Dose Versus Standard Warfarin After Mechanical Mitral Valve Replacement: A Randomized Controlled Trial. Ann Thorac Surg. 2022: S 0003–4975 (22) 00138–2. DOI: 10.1016/j.athoracsur.2022.01.015.

12. Labaf A., Svensson P. J., Renlund H., Jeppsson A., Själander A. Incidence and risk factors for thromboembolism and major bleeding in patients with mechanical valve prosthesis: a nationwide population-based study. Am 9 Heart J. 2016; 181: 1–9. DOI: 10.1016/j.ahj.2016.06.026.

13. İlker K., Ali E. K. Assessment of the warfarin anticoagulation knowledge of patients with mechanical mitral valve prosthesis and its effect on therapy adherence and relevant complications. Fam Med Prim Care Rev. 2021; 3 (2): 174–178. DOI: 10.5114/fmpcr.2021.105919.